Guowen Wang
Bengbu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Evaluation of the efficacy and safety of neoadjuvant immunotherapy in locally advanced esophageal squamous cell carcinoma.
Journal: Journal of thoracic disease
Published: February 05, 2025
TFAP2A Transcriptionally Activates CST2 to Promote the Malignant Progression of Non-Small Cell Lung Cancer.
Journal: Journal of biochemical and molecular toxicology
Published: September 19, 2024
Inhibition of Chitinase-3-like Protein 1 Reduced Epithelial-Mesenchymal Transition and Vascular Epithelial Cadherin Expression in Oesophageal Squamous Cell Carcinoma.
Journal: Iranian journal of biotechnology
Published: July 18, 2024
Comprehensive analysis of risk factors for surgical site infections following thoracoscopic radical resection in patients with lung cancer.
Journal: International wound journal
Published: October 25, 2023
Pan-cancer analyses of classical protein tyrosine phosphatases and phosphatase-targeted therapy in cancer.
Journal: Frontiers in immunology
Published: June 24, 2022
PTPN18 Serves as a Potential Oncogene for Glioblastoma by Enhancing Immune Suppression.
Journal: Oxidative medicine and cellular longevity
Published: March 15, 2022
Thoracoscopic Lobectomy versus Segmentectomy in the Treatment of Patients with Early-Stage Lung Cancer.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: March 08, 2022
Nuclear import of PTPN18 inhibits breast cancer metastasis mediated by MVP and importin β2.
Journal: Cell death & disease
Published: March 04, 2022
A TP53 Related Immune Prognostic Model for the Prediction of Clinical Outcomes and Therapeutic Responses in Lung Adenocarcinoma.
Journal: Frontiers in immunology
Published: February 15, 2022
Upregulation of exosomal circPLK1 promotes the development of non-small cell lung cancer through the miR-1294/ high mobility group protein A1 axis.
Journal: Bioengineered
Published: February 04, 2022
Anlotinib Combined with Cranial Radiotherapy for Non-Small Cell Lung Cancer Patients with Brain Metastasis: A Retrospectively, Control Study.
Journal: Cancer management and research
Published: May 11, 2021
Knockdown of PNO1 inhibits esophageal cancer progression.
Journal: Oncology reports
Published: July 23, 2020
Last Updated: 09/26/2026